Masayuki Haruta

1.0k citations

44 papers · 770 indexed · h-index 18

Cancer Research
Molecular Biology
- Epigenetics and DNA Methylation 15
- Renal and related cancers 14
- Cancer-related gene regulation 6
- RNA modifications and cancer 4
Genetics top 10%
- Genetic Syndromes and Imprinting 8
Pediatrics, Perinatology and Child Health top 10%
- Prenatal Screening and Diagnostics 4
Oncology
Neurology
- Neuroblastoma Research and Treatments 9
Surgery
- Bladder and Urothelial Cancer Treatments 4

Co-authors: Yasuhiko Kaneko Shohei Honda Yasuhito Arai Hiroshi Horie Masahiro Fukuzawa Hajime Okita Akira Nakagawara Miki Ohira
Cited by: Cancer Research Molecular Biology Genetics
Journals: Oncogene (1 paper)Current Biology (1 paper)Biochemical and Biophysical Research Communications (1 paper)
Partner nations: Japan United Kingdom Indonesia

In The Last Decade

Masayuki Haruta

42 papers receiving 764 citations

Peers

Countries citing papers authored by Masayuki Haruta

Since Specialization

Citations

This map shows the geographic impact of Masayuki Haruta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Haruta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Haruta more than expected).

Fields of papers citing papers by Masayuki Haruta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Haruta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Haruta. The network helps show where Masayuki Haruta may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Masayuki Haruta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Masayuki Haruta Line = papers co-authored together Masayuki Haruta links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-γ-induced Apoptosis in Urothelial Cancer Anticancer Research ·Hirotaka Fuchizawa,Kiyohiro Ando,Noriko Motoi,Toshihiko Iizuka,Masaharu Inoue,Kouki Mitani,YUTA SANO,Hisanori Takenobu,Masayuki Haruta,Ritsuko Onuki,Yoh Matsuoka,Takehiko Kamijo,Yukio Kageyama	2024	1
2	Positive regulatory loop of platelet-derived growth factor DD-induced STAT3 activation is associated with poor prognosis in advanced urothelial carcinoma Biochemical and Biophysical Research Communications ·Kiyohiro Ando,Ryo Kurashina,Noriko Motoi,Toshihiko Iizuka,Masaharu Inoue,Riko Maruyama,Kouki Mitani,Hisanori Takenobu,Masayuki Haruta,Ritsuko Onuki,Yoh Matsuoka,Takehiko Kamijo,Yukio Kageyama	2023	1
3	ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors BMC Cancer ·Sultana Parvin,Jesmin Akter,Hisanori Takenobu,Yutaka Katai,Shunpei Satoh,Ryu Okada,Masayuki Haruta,Kyosuke Mukae,Tomoko Wada,Miki Ohira,Kiyohiro Ando,Takehiko Kamijo	2023	8
4	Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell‐derived neural crest cells Cancer Science ·Kyosuke Mukae,Hisanori Takenobu,Yuki Endo,Masayuki Haruta,Tianyuan Shi,Shunpei Satoh,Miki Ohira,Michinori Funato,Junya Toguchida,Kenji Osafune,Tatsutoshi Nakahata,Hiroaki Kanda,Takehiko Kamijo	2023	6
5	Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma Anticancer Research ·Ryo Kurashina,Kiyohiro Ando,Masaharu Inoue,Keita Izumi,Riko Maruyama,Kouki Mitani,Hisanori Takenobu,Masayuki Haruta,Toshihiko Iizuka,Takehiko Kamijo,Yukio Kageyama	2022	15
6	Combined Genetic and Chromosomal Characterization of Wilms Tumors Identifies Chromosome 12 Gain as a Potential New Marker Predicting a Favorable Outcome Neoplasia ·Masayuki Haruta,Yasuhito Arai,Hajime Okita,Yukichi Tanaka,Tetsuya Takimoto,Ryuichi P. Sugino,Yasuhiro Yamada,Takehiko Kamijo,Takaharu Oue,Masahiro Fukuzawa,Tsugumichi Koshinaga,Yasuhiko Kaneko	2018	7
7	EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications Oncogene ·Zhenghao Li,Hisanori Takenobu,Amallia Nuggetsiana Setyawati,Nobuhiro Akita,Masayuki Haruta,Shunpei Satoh,Yoshitaka Shinno,Koji Chikaraishi,Kyosuke Mukae,Jesmin Akter,Ryuichi P. Sugino,Atsuko Nakazawa,Akira Nakagawara,Hiroyuki Aburatani,Miki Ohira,Takehiko Kamijo	2018	53
8	Anaplastic histology Wilms’ tumors registered to the Japan Wilms’ Tumor Study Group are less aggressive than that in the National Wilms’ Tumor Study 5 Pediatric Surgery International ·Takaharu Oue,Tsugumichi Koshinaga,Tetsuya Takimoto,Hajime Okita,Yukichi Tanaka,Miwako Nozaki,Masayuki Haruta,Yasuhiko Kaneko,Masahiro Fukuzawa	2016	11
9	RASSF1A methylation may have two biological roles in neuroblastoma tumorigenesis depending on the ploidy status and age of patients Cancer Letters ·Masayuki Haruta,Takehiko Kamijo,Akira Nakagawara,Yasuhiko Kaneko	2014	8
10	Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy BMC Cancer ·Mamoru Takada,Toru Higuchi,Katsunori Tozuka,Hiroyuki Takei,Masayuki Haruta,Junko Watanabe,Fumio Kasai,Kenichi Inoue,Masafumi Kurosumi,Masaru Miyazaki,Aiko Sato‐Otsubo,Seishi Ogawa,Yasuhiko Kaneko	2013	22
11	Different incidences of epigenetic but not genetic abnormalities between Wilms tumors in Japanese and Caucasian children Cancer Science ·Masayuki Haruta,Yasuhito Arai,Naoki Watanabe,Yuiko Fujiwara,Shohei Honda,Junjiro Ohshima,Fumio Kasai,Hisaya Nakadate,Hiroshi Horie,Hajime Okita,Junichi Hata,Masahiro Fukuzawa,Yasuhiko Kaneko	2012	20
12	Meiosis error and subsequent genetic and epigenetic alterations invoke the malignant transformation of germ cell tumor Genes Chromosomes and Cancer ·Mizuho Ichikawa,Yasuhito Arai,Masayuki Haruta,Shinsuke Furukawa,Tadashi Ariga,Tadashi Kajii,Yasuhiko Kaneko	2012	6
13	Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor Genes Chromosomes and Cancer ·Junjiro Ohshima,Masayuki Haruta,Yasuhito Arai,Fumio Kasai,Yuiko Fujiwara,Tadashi Ariga,Hajime Okita,Masahiro Fukuzawa,Junichi Hata,Hiroshi Horie,Yasuhiko Kaneko	2009	31
14	Duplication of paternal IGF2 or loss of maternal IGF2 imprinting occurs in half of Wilms tumors with various structural WT1 abnormalities Genes Chromosomes and Cancer ·Masayuki Haruta,Yasuhito Arai,Waka Sugawara,Naoki Watanabe,Shohei Honda,Junjiro Ohshima,Hidenobu Soejima,Hisaya Nakadate,Hajime Okita,Junichi Hata,Masahiro Fukuzawa,Yasuhiko Kaneko	2008	37
15	Centrosome amplification is correlated with ploidy divergence, but not with MYCN amplification, in neuroblastoma tumors Cancer Genetics and Cytogenetics ·Daisuke Fukushi,Naoki Watanabe,Fumio Kasai,Masayuki Haruta,Akira Kikuchi,Atsushi Kikuta,Koji Kato,Hisaya Nakadate,Yukiko Tsunematsu,Yasuhiko Kaneko	2008	5
16	Experience-Driven Axon Retraction without Binocular Imbalance in Developing Visual Cortex Current Biology ·Masayuki Haruta,Yoshio Hata	2007	12
17	Duplication of the paternal IGF2 allele in trisomy 11 and elevated expression levels of IGF2 mRNA in congenital mesoblastic nephroma of the cellular or mixed type Genes Chromosomes and Cancer ·Naoki Watanabe,Masayuki Haruta,Hidenobu Soejima,Daisuke Fukushi,Kinji Yokomori,Hisaya Nakadate,Hajime Okita,Junich Hata,Masahiro Fukuzawa,Yasuhiko Kaneko	2007	13
18	Promoter hypermethylation of the RASSF1A gene predicts the poor outcome of patients with hepatoblastoma Pediatric Blood & Cancer ·Waka Sugawara,Masayuki Haruta,Fumiaki Sasaki,Naoki Watanabe,Yukiko Tsunematsu,Atsushi Kikuta,Yasuhiko Kaneko	2006	29
19	A new imprinted cluster on the human chromosome 7q21-q31, identified by human-mouse monochromosomal hybrids Genomics ·Chiga Okita,Makiko Meguro,Hidetoshi Hoshiya,Masayuki Haruta,Yuki Sakamoto,Mitsuo Oshimura	2003	66
20	Predominant maternal expression of the mouse Atp10c in hippocampus and olfactory bulb Journal of Human Genetics ·Akiko Kashiwagi,Makiko Meguro,Hidetoshi Hoshiya,Masayuki Haruta,Fumitoshi Ishino,Toshiyuki Shibahara,Mitsuo Oshimura	2003	34

About Masayuki Haruta

Masayuki Haruta is a scholar working on Neurology, Molecular Biology and Genetics, having authored 44 papers that have together received 770 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (15 papers), Renal and related cancers (14 papers), Neuroblastoma Research and Treatments (9 papers), Genetic Syndromes and Imprinting (8 papers), Cancer-related gene regulation (6 papers), Bladder and Urothelial Cancer Treatments (4 papers), Prenatal Screening and Diagnostics (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (141 citations), Molecular Biology (599 citations) and Genetics (193 citations). Masayuki Haruta has collaborated with scholars based in Japan, United Kingdom and Indonesia. Frequent co-authors include Yasuhiko Kaneko, Shohei Honda, Yasuhito Arai, Hiroshi Horie, Masahiro Fukuzawa, Hajime Okita, Akira Nakagawara, Miki Ohira, Eiso Hiyama and Mitsuo Oshimura. Their work appears in journals such as Oncogene, Current Biology and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact